- Home
- TCX vs KYTX Comparison
TCX vs KYTX Comparison
Compare TCX & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- KYTX
- Stock Information
- Founded
- TCX 1992
- KYTX 2018
- Country
- TCX Canada
- KYTX United States
- Employees
- TCX N/A
- KYTX N/A
- Industry
- TCX EDP Services
- KYTX
- Sector
- TCX Technology
- KYTX
- Exchange
- TCX Nasdaq
- KYTX NYSE
- Market Cap
- TCX 179.0M
- KYTX 196.4M
- IPO Year
- TCX 1996
- KYTX 2024
- Fundamental
- Price
- TCX $15.55
- KYTX $3.98
- Analyst Decision
- TCX
- KYTX Buy
- Analyst Count
- TCX 0
- KYTX 5
- Target Price
- TCX N/A
- KYTX $23.20
- AVG Volume (30 Days)
- TCX 47.1K
- KYTX 453.0K
- Earning Date
- TCX 02-20-2025
- KYTX 02-12-2025
- Dividend Yield
- TCX N/A
- KYTX N/A
- EPS Growth
- TCX N/A
- KYTX N/A
- EPS
- TCX N/A
- KYTX N/A
- Revenue
- TCX $356,135,000.00
- KYTX N/A
- Revenue This Year
- TCX $8.16
- KYTX N/A
- Revenue Next Year
- TCX N/A
- KYTX N/A
- P/E Ratio
- TCX N/A
- KYTX N/A
- Revenue Growth
- TCX 7.50
- KYTX N/A
- 52 Week Low
- TCX $15.01
- KYTX $3.63
- 52 Week High
- TCX $28.66
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- TCX 35.65
- KYTX 38.40
- Support Level
- TCX $15.64
- KYTX $3.63
- Resistance Level
- TCX $17.11
- KYTX $4.60
- Average True Range (ATR)
- TCX 0.92
- KYTX 0.45
- MACD
- TCX -0.22
- KYTX -0.10
- Stochastic Oscillator
- TCX 6.05
- KYTX 8.58
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.